Zhang, C., Duan, S., Guo, M., Yuan, Y., Huang, Z., Zhu, J., . . . Xing, C. (2020). Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy. Pharmgenomics Pers Med.
Chicago Style CitationZhang, Chengning, Suyan Duan, Miao Guo, Yanggang Yuan, Zhimin Huang, Jingfeng Zhu, Bin Sun, Bo Zhang, i Changying Xing. "Effects of CYP3A5 Polymorphisms On Efficacy and Safety of Tacrolimus Therapy in Patients With Idiopathic Membranous Nephropathy." Pharmgenomics Pers Med 2020.
Cita MLAZhang, Chengning, et al. "Effects of CYP3A5 Polymorphisms On Efficacy and Safety of Tacrolimus Therapy in Patients With Idiopathic Membranous Nephropathy." Pharmgenomics Pers Med 2020.
Atenció: Aquestes cites poden no estar 100% correctes.